Your browser doesn't support javascript.
loading
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Tian, Xue-Li; Suo, Bao-Jun; Zhang, Hua; Lu, Hao-Ping; Li, Cai-Ling; Zhang, Yu-Xin; Ren, Xin-Lu; Yao, Xing-Yu; Zhou, Li-Ya; Song, Zhi-Qiang.
Afiliação
  • Tian XL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Suo BJ; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
  • Lu HP; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Li CL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Zhang YX; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Ren XL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Yao XY; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Zhou LY; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Song ZQ; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Helicobacter ; 28(1): e12935, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36374159

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Helicobacter pylori / Infecções por Helicobacter Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Helicobacter Assunto da revista: BACTERIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Helicobacter pylori / Infecções por Helicobacter Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Helicobacter Assunto da revista: BACTERIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China